Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H12N2OS2 |
| Molecular Weight | 300.399 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(SC2=C3C=C(SC3=CN=C2)C(N)=O)C=C1
InChI
InChIKey=QQGWEXFLMJGCAL-UHFFFAOYSA-N
InChI=1S/C15H12N2OS2/c1-9-2-4-10(5-3-9)19-13-7-17-8-14-11(13)6-12(20-14)15(16)18/h2-8H,1H3,(H2,16,18)
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11300880Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11856042
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11300880
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/11856042
A-205804 is a potent and selective inhibitor of E-selectin and ICAM-1 expression with IC50 of 20 nM and 25 nM respectively. Pharmaceutical agents which would prevent the induced expression of one or more of the cell adhesion molecules on the endothelium might be expected to provide a novel mechanism to attenuate the inflammatory responses associated with chronic inflammatory diseases.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11300880
Curator's Comment: # Andrew O. Stewart et al., Abbott Laboratories
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3890 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11300880 |
20.0 nM [IC50] | ||
Target ID: CHEMBL3070 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11300880 |
25.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis and mode of action of (125)I- and (3)H-labeled thieno[2,3-c]pyridine antagonists of cell adhesion molecule expression. | 2002-02-08 |
|
| Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides. | 2001-10-11 |
|
| Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expression. | 2001-03-15 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11300880
A-205804 selectively inhibits the surface expression of the cell adhesion molecules ICAM-1 and E-selectin in human endothelial cells. A-205804 inhibites the IL-1β-induced expression of E-selectin (IC50 = 20 nM) and ICAM-1 (IC50 = 10 nM) with essentially the same level of potency as that for TNFα-induced expression.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80179864
Created by
admin on Mon Mar 31 22:14:41 GMT 2025 , Edited by admin on Mon Mar 31 22:14:41 GMT 2025
|
PRIMARY | |||
|
TP7TB1SSZD
Created by
admin on Mon Mar 31 22:14:41 GMT 2025 , Edited by admin on Mon Mar 31 22:14:41 GMT 2025
|
PRIMARY | |||
|
251992-66-2
Created by
admin on Mon Mar 31 22:14:41 GMT 2025 , Edited by admin on Mon Mar 31 22:14:41 GMT 2025
|
PRIMARY | |||
|
9839311
Created by
admin on Mon Mar 31 22:14:41 GMT 2025 , Edited by admin on Mon Mar 31 22:14:41 GMT 2025
|
PRIMARY |
ACTIVE MOIETY